Lexeo Therapeutics (LXEO) Shares Outstanding (Diluted Average) (2022 - 2026)

Lexeo Therapeutics' Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $81.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 145.16% year-over-year to $81.2 million; the TTM figure through Mar 2026 stood at $81.2 million (up 145.16% YoY), while the FY2025 annual figure was $53.6 million, up 68.76% from the prior year.
• Shares Outstanding (Diluted Average) came in at $81.2 million for Q1 2026 at Lexeo Therapeutics, up from $53.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $81.2 million in Q1 2026 to a low of $1.6 million in Q1 2023.
• A 5-year average of $27.5 million and a median of $31.8 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• Across the five-year window, Shares Outstanding (Diluted Average) declined 0.4% in 2023 and soared 1942.0% in 2024, its largest moves.
• Lexeo Therapeutics' Shares Outstanding (Diluted Average) stood at $1.6 million in 2022, then soared by 228.42% to $5.4 million in 2023, then soared by 493.67% to $31.8 million in 2024, then surged by 68.76% to $53.6 million in 2025, then jumped by 51.33% to $81.2 million in 2026.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $81.2 million, $53.6 million, and $61.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison